Commonwealth Numbered Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Download] [Help]

HEALTH INSURANCE (DIAGNOSTIC IMAGING SERVICES TABLE) AMENDMENT REGULATIONS 2009 (NO. 6) (SLI NO 370 OF 2009) - SCHEDULE 1

Amendments

(regulation 3)

 

[1]           Schedule 1, Part 3, after item 61368

insert

61369

Indium-labelled octreotide study, including single photon emission tomography when undertaken, if:

   (a)  a gastro-entero-pancreatic endocrine tumour is suspected, based on biochemical evidence, with negative or equivocal conventional imaging; or

   (b)  a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, to exclude additional disease sites (R)

2 015.75

[2]           Schedule 1, Part 3, item 61505, note

omit

[3]           Schedule 1, Part 3, after item 61505, in Group I4

insert

61650

LeukoScan study of the long bones and feet for suspected osteomyelitis, if patient does not have access to ex-vivo white blood cell scanning (R)

Note    LeukoScan is only indicated for diagnostic imaging in a patient suspected of infection of the long bones and feet, including those with diabetic ulcers. The descriptor does not cover a patient who is being investigated for other sites of infection.

878.70



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback